Showing results (3071-3080 of 45,231) with videos related to

Sort By:
Pageof 4,524
Cancer Research|March 1, 1982
Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II)H B Niell, C A Wood, D D Mickey, et al.
Cancer Research|March 1, 1982
Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustardJ M Ducore, L C Erickson, L A Zwelling, et al.
Cancer Research|March 1, 1982
Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in ratsW J Hrushesky, F A Levi, F Halberg, et al.
Cancer Research|July 1, 1982
Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitroB T Hill, S A Whatley, A S Bellamy, et al.
Cancer Research|October 24, 2019
A Single-Step, High-Dose Selection Scheme Reveals Distinct Mechanisms of Acquired Resistance to Oncogenic Kinase Inhibition in Cancer CellsKenneth J Finn, Scott E Martin, Jeff Settleman
Cancer Research|July 15, 1988
Significance of altered alpha-2-L-fucosyltransferase levels in serum of leukemic patientsP O Skacel, W M Watkins
Cancer Research|November 1, 1981
Differential response to elutriated 9L cells to treatment with 1,3-bis(2-chloroethyl)-1-nitrosoureaT Hoshino, D F Deen, M E Williams, et al.
Cancer Research|November 1, 1981
Potency of some carbamates as multiple tissue sister chromatid exchange inducers and comparison with known carcinogenic activitiesM Cheng, M K Conner, Y Alarie
Cancer Research|November 1, 1981
Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promotersD L Laskin, J D Laskin, F K Kessler, et al.
Cancer Research|November 1, 1981
Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amideE Pearlstein, C Ambrogio, G Gasic, et al.
Pageof 4,524